Sort   by:  
 Page size 
UnknownA new FGFR inhibitor disrupts the TGF-β1-induced fibrotic process.
Not available
S-EPMC6933341 | biostudies-literature
UnknownComparison of coronary computed tomography angiography image quality with high- and low-concentration contrast agents (CONCENTRATE): study protocol for a randomized controlled trial.
Not available
S-EPMC4946231 | biostudies-literature
UnknownThe integrity of thalamo-dorsolateral prefrontal cortex tract: a key factor in residual consciousness in disorders of consciousness patients.
Not available
S-EPMC11349516 | biostudies-literature
UnknownPatient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10).
Not available
S-EPMC7694364 | biostudies-literature
TranscriptomicsIntergrated expression profiling and ChIP-SEQ analyses of ChREBP-mediated glucose response network (expression data only)
We identified ChREBP-binding regions from the DNA of human hepatocellular targets as well as previously-known targets Total RNA from hepG2 cell line
ORGANISM(S): Homo sapiens 
2010-06-16 | E-GEOD-22074 | biostudies-arrayexpress
UnknownImpact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
Not available
S-EPMC6954564 | biostudies-literature
UnknownMicroglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2.
Not available
S-EPMC11425970 | biostudies-literature
UnknownGenome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
Not available
S-EPMC5511346 | biostudies-literature
UnknownNTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.
Not available
S-EPMC8439610 | biostudies-literature
UnknownLatrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function.
Not available
S-EPMC9166773 | biostudies-literature
Sort   by:  
 Page size